Astellas Pharma Korea will now be run by a Korean head.

According to industry sources, Junil Kim (50) was appointed to succeed Marker Weber and head the Korean subsidiary of Astellas Pharma.

With the appointment, Astellas Korea will be welcoming the first Korean head in 7 years since the resignation of Jung Hae-doh in 2017. After Jung, Astellas Korea maintained a foreign representative system, appointing Takenoya Osamu, Masujima Keita, then Marcus Weber as General Manager of the Korean subsidiary.

Junil Kim is a seasoned veteran in the field. After graduating from Chung-Ang University School of Pharmacy, Kim entered the industry as a medical representative for GSK Korea,